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Vaccines are an important component ofhealthcare in the world today. Vaccines are able 
to prevent people from getting many diseases and provide protection for the future. However, 
many people have concerns over the safety of vaccines and question why they are necessary. 
Many people are beginning to not have their children vaccinated out of fear for what the vaccine 
will do, such as cause autism. In this paper I provide the basic immunology information that is 
important to understand vaccines, the types of vaccines used, information on common vaccines, 
information on the safety of vaccines, and I address some of the concerns of parents, in particular 
the fear of autism caused by vaccines. 
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Process Analysis Statement 
As a biochemistry major I have had the opportunity to take many biology and chemistry 
classes over the course of my time at Ball State. In the fall of 2016 I took an immunology class 
that was very interesting to me. This class led to me wanting to conduct my thesis over the topic 
of vaccines. I am also a pre-pharmacy major and plan to go to pharmacy school to become a 
pharmacist. The topic of vaccines is pertinent to this area because as a pharmacist I will have to 
administer vaccines to people and will need to be knowledgeable about vaccines. Researching 
the history of vaccines and how they work will give me more knowledge and understanding 
about vaccinations. 
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The target audience for this thesis will be anyone interested in learning more about the 
benefits of vaccines, whether they are just curious or they are trying to decide whether or not 
they should vaccinate their children or be vaccinated themselves. I expect others to learn how 
vaccines are used and how they have helped to eliminate diseases. I expect them to learn some of 
the biological functions of vaccines so that they fully understand how vaccinations work. 
Recently the topic of whether or not parents should vaccinate their children has been a 
controversial topic and I hope to educate people about the safety of vaccines in this thesis. 
I began work on my thesis by outlining what topics I wanted to cover. I know that not 
everyone fully understands how vaccines work and so I wanted to incorporate that into my 
thesis. I did not want to get to technical so that anyone, no matter their knowledge background 
could understand it. I also wanted to discuss the different types of vaccines that are used since 
this is a major component of educating people about vaccinations. I included some information 
on many of the common vaccines used so that this thesis could be an inclusive and one stop 
paper for those wanting to be educated on vaccines. Finally, I thought it was very important to 
include a section on the safety of vaccines as this is a major issue for those who do not want to 
have their children or themselves vaccinated. In the same area of safety I also included some 
information on the myth that vaccines, the MMR vaccine specifically, causes autism. 
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Completing this thesis was a daunting task as I have never considered myself to be that 
great of a writer. I found that setting due dates throughout the semester was very beneficial. 
However, I also discovered I am not as good at time management as I thought, although this 
project has definitely allowed be to learn how to be better at it. I did hit a few road blocks when 
writing this thesis, mostly because I could not find good articles to reference. But I was able to 
work through the road blocks and produce a complete thesis. I have never written or worked on a 
project of this caliber and from the beginning I was not sure how I could do it. But now that it is 
completed it has given me the confidence to know I can do anything as long as I work hard at it 
and do not give up. Following is a thesis on vaccines that I am very proud to say that I wrote. 
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What is a vaccine? 
Illnesses are a common occurrence in the world today. Every year the flu alone causes 
many people to be hospitalized and can even lead to death. Since 2010 the CDC estimates that 
between 140,000 and 710,000 people were hospitalized due to the flu and between 12,000 and 
56,000 died due to the flu (Key Facts ... 2017). However, with the invention of vaccines some 
diseases and sicknesses are being prevented. To understand vaccines it' s important to first 
discuss the immunology component of them. One must also understand the body and how the 
immune system fights off diseases and illnesses. Once this is known then vaccines can begin to 
be understood. There are different types of immunity along with different types of vaccines that 
are utilized. Vaccines are used to help protect people from diseases and prevent them from 
getting certain diseases. Vaccines have been created for many diseases and most are 
administered at young ages. Some of the vaccines that have been created are for smallpox, 
diphtheria, pertussis, measles, mumps, rubella, and more. Because of vaccines smallpox has been 
completely eradicated and 99% of polio cases have been reduced (Zepp 2010). However, for the 
past twenty years concerns have been growing over vaccines and their safety. Some individuals 
have even begun making the choice to not get vaccinated or to not vaccinate their children, 
thinking that the vaccines cause other problems, such as autism. 
Basic Immunology Components 
There are two components to the immune system ofthe human body, the innate and 
adaptive immune systems. The innate system works first to ward off pathogens and provides 
protection against letting pathogens inside the body. If needed the adaptive system comes into 
play and provides a stronger defense. The adaptive system involves B and T cells that work 
inside the body to kill any pathogen that made its way past the innate protection. These systems 
work together to fight off invading pathogens, bacterium, viruses, or other microorganisms that 
can cause disease or illness (Dictionary.com). 
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The innate immune system gives a general defense to pathogens. The responses to the 
innate immune system are not specific to one pathogen but instead respond to recognized 
patterns on many pathogens (Clem 2011). The fact that the innate system does not give specific 
responses means that it cannot not retain memory. The components of the innate immune system 
cannot remember certain pathogens and cannot build up a stronger defense to the same pathogen 
if encountered again (Clem 2011). 
The components ofthe innate immune system include the skin and mucous membranes 
(Clem 2011). The skin provides protection because it is very acidic which prevents organisms 
from growing on it (Clem 2011 ). The mucous membranes work by helping to capture and expel 
microorganisms from the body. These membranes are found along the tracts in the body such as 
the respiratory and digestive tracts, along with lining the mouth, nose, eyelids, trachea, lungs, 
intestines, and stomach (Encyclopedia Britannica). However, these membranes do not affect the 
normal microorganisms that are always a part of the body. In fact, the normal microorganisms 
that reside on the skin and membranes provide some protection by allowing less room for 
harmful bacteria or organisms to grow. Other components of the innate immune system include 
the body's temperature, the acidic gastric juices, and lysozymes (Clem 2011). The body's 
temperature can prevent some organisms from surviving if they typically thrive at a different 
temperature, whether higher or lower. The juices in the stomach are very acidic which inhibits 
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many organisms from living. Lysozymes are enzymes in tears and other mucus secretions which 
can aid in the breakdown of the cell wall on invading pathogens (Clem 2011). 
There are also certain responses that occur in the innate immune system that help fight 
invading organisms. One response of the innate immune system is the inflammatory response 
which includes fever, redness, swelling, heat, and pain (Clem 2011). This response works to kill 
the invading pathogen. Another major component of the innate immune system is the 
complement response which consists of three pathways that come together creating a complex 
called the membrane attack complex. This complex then constructs pores in the harinful cells 
that caused the response and leads to the cell ' s death (Clem 2011). The three pathways of 
complement also produce anaphylatoxins that are an important component of and enhance the 
inflammatory response (Sarma J and Ward P 2011). Anaphylatoxins act as chemoattractants in 
which they attract phagocytes (Sarma J and Ward P 2011 ), or a cell that can ingest bacteria, 
foreign particles, and other cells, to the area of inflammation (Phagocyte). They also function as 
vasodilators, promote contraction of smooth muscle, and induce the release of histamine (Sarma 
J and Ward P 2011). 
Another way the innate immune system works is by using pattern recognition receptors 
(PRRs ). PRRs are membrane proteins that can recognize pathogen associated molecular patterns 
(P AMPs) on invading pathogens. An important example of a PRR is a toll-like receptor (TLR). 
There are many TLRs that have been identified and while they each have a specific function, 
overall they work to recognize the components of invading microbes or pathogens (Takeda K 
and Akira S 2005). When PRRs recognize P AMPS it triggers activation of complement, release 
of cytokines, activation ofphagocytes, and opsonization (Clem 2011), which is the process by 
which bacteria and other cells are altered in such a manner that they are more readily and more 
efficiently engulfed by phagocytes (Opsonization). Examples ofPAMPs that PRRs can 
recognize are the endotoxin LPS, peptidoglycan, double-stranded DNA in viruses, flagellin, 
lipoproteins, and hypomethylated DNA (Clem 2011). Together these components of the innate 
system work to keep microorganisms and pathogens from invading too far. However, when the 
pathogen or microorganism is able to evade the innate immune system, the adaptive immune 
system comes into play. 
6 
The adaptive immune system is different from the innate in that it responds more 
specifically to the invading pathogen. The adaptive immune system also has memory capability 
which means that it can remember specific pathogens and will be able to build up a stronger 
response when the pathogen is encountered again. However, the adaptive immune response takes 
longer than the innate immune response. The adaptive immune system consists of B cells and T 
cells and these cells generate two types of immune responses. B cells are a part of antibody-
mediated immunity, also called humoral immunity, and T cells are part of cell-mediated 
immunity (Clem 2011). Together these cells work to carry out the functions ofthe adaptive 
immune system. 
B cells are made and mature in the bone marrow and then move to a secondary lymphoid 
organ which include lymph nodes, spleen, tonsil, or Peyer patches (Clem 2011 and Pieper et al 
2013). The job ofB cells is to recognize extracellular antigens or toxins. They can be activated 
by antigens alone through the B-cell receptor or they can be further activated by helper T cells 
(Pierce 2002). When B cells are activated by aritigens alone, the response is not very strong and 
there is not much memory. Therefore, B cells will typically need additional activation by helper 
T cells (Pierce 2002). When helper T cells help activate B cells, there is a much stronger immune 
response and stronger memory (Clem 2011 ). The recognition of antigens by B cells then causes 
the B cell to grow into a plasma cell. The plasma cells then produce antibodies to the specific 
antigen. Many copies of the activated B cells can then be made and they can become either 
plasma cells or memory B cells, which stay in the lymph node in case the pathogen is 
encountered again (Clem 2011). 
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T cells are made in the bone marrow, move to and mature in the thymus, and then move 
into the blood (Clem 2011 ). There are two types ofT cells and both of their jobs is to recognize 
intracellular antigens. The CD4 T cells recognize cells that have the protein called the major 
histocompatibility complex II protein (Clem 2011 ). The cells with this protein are immune cells 
and therefore CD4 T cells interact with immune cells. CD4 T cells are the helper T cells 
mentioned previously. These cells help activate the B cells and are important for antibody-
mediated immunity (Clem 2011). The other type ofT cells are the CDS T cells which are 
important for cell-mediated immunity. These cells are also called cytotoxic T cells and recognize 
cells with the major histocompatibility complex I protein. Cells with this complex are all 
nucleated or professional antigen presenting cells and therefore CDS T cells act to mark body 
cells (Clem 2011). T cells are only able to recognize an antigen if it has been processed and then 
presented by an antigen-presenting cell (Clem 2011 ). After a T cell is activated, many copies can 
be made to become either effector T cells that work to fight against invading pathogens or 
memory T cells that stay in case the pathogen is encountered again. 
Passive and Active Immunity 
There are two different types of immunity, passive and active. Passive immunity can be 
natural or acquired immunity and it, "refers to the process of providing IgG antibodies to protect 
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against infection," (Baxter 2007). This type of immunity does not last for a long amount oftime, 
usually from a few weeks and up to about 3 months (Baxter 2007). However, its effect is 
immediate. An example of natural passive immunity is the passing of maternal antibody to the 
baby across the placenta. To receive acquired passive immunity, serum or immunoglobulin from 
an immune person is collected, pooled, and the immunoglobulin is concentrated and then 
injected into the person needing the immunity (Baxter 2007). An example of acquired passive 
immunity is the use of human hepatitis B immunoglobulin that is given to workers in health care 
who are exposed to the hepatitis B viruses (Baxter 2007). 
Active immunity is when a person is exposed to an antigen in order to stimulate an 
adaptive immune response (Baxter 2007). This response is not immediate like in passive 
immunity but instead can take days or weeks. However, unlike passive immunity, the response 
can last for a long time (Baxter 2007). Since the adaptive immune response is activated in active 
immunity, the memory capability is also activated. This means memory cells that are made can 
remember specific pathogens and will be able to respond more strongly when the pathogen is 
encountered again. Active immunity also can be acquired or natural (Baxter 2007). An example 
of natural active immunity is becoming infected with the hepatitis A virus but then recovering 
(Baxter 2007). This provides the person with further protection from becoming infected again. 
An example of acquired active immunity is instead being given the hepatitis A vaccine. When 
given two doses of this vaccine a long-lasting immune response is stimulated (Baxter 2007). 
Vaccine Types 
There are four different types of vaccines and they are classified based on the type of 
antigen used. The four types are toxoid, subunit, live attenuated, and killed inactivated. Each 
vaccine type also contains other components in them that can help enhance the immune 
response, help stabilize the product, are the carrier used for delivery of the vaccine, or is a 
leftover from the manufacturing process (Baxter 2007). The vaccine type used depends on what 
infectious disease is trying to be prevented. 
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Toxoid vaccines are a vaccine used against diseases that are caused by exotoxins. For a 
toxoid vaccine, a toxoid is created that is very similar to the original toxin and this allows for 
cross-reacting antibodies (Baxter 2007). The main goal of the toxoid vaccine is to create 
antibodies against the toxoid that are better able to bind the toxin than are the nerve cells in the 
body (Baxter 2007). Examples of toxoid vaccines include tetanus, diphtheria, botulism, pertussis, 
and cholera. Toxoid vaccines are not very immunogenic so many doses need to be used along 
with an adjuvant (Baxter 2007). The adjuvant helps enhance the immune response to make it 
more long-lasting so that a large amount of the toxoid does not have to be used (Baxter 2007). 
In a subunit vaccine a certain antigen is used or a combination of antigens are used to 
generate antibodies against a specific component of a pathogen instead of stimulating antibodies 
against all antigens of the pathogen (Baxter 2007). A subunit vaccine elicits an immune response 
that differs depending on if the antigen in the vaccine is a protein or a polysaccharide. Examples 
of a subunit vaccine are Hepatiti~ B, Haemophilus influenzae b, and influenza. Hepatitis B and 
Haemophilus influenzae b use only one antigen while influenza uses two antigens (Baxter 2007). 
Subunit vaccines are similar to toxoid vaccines in that they also require the use of an adjuvant. 
A live attenuated vaccine uses an attenuated form of the pathogen. This means that the 
pathogen is still capable of replication but is weakened. One method of attenuating the pathogen 
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is growing it in a foreign host. It then replicates and mutants are formed. The mutants that have a 
higher virulence in the foreign host are chosen because they typically have a lower virulence in 
the human host and therefore would work well in the vaccine (Baxter 2007). Another method for 
attenuation is growing the pathogen in an artificial growth medium at a temperature that is lower 
than the body's temperature. Given time a strain could appear that can grow at the lower 
temperature but grows so slowly that in the human host there would be sufficient time for an 
immune response to take place and kill the pathogen (Baxter 2007). Examples of live attenuated 
vaccines include measles, mumps, chickenpox, and rubella. A major disadvantage with this type 
of vaccine however, is the possibility to cause the illness the vaccine is trying to prevent (Baxter 
2007). However, this only happens if the pathogen returns to a harmful state or if an individual is 
immunocompromised and therefore the pathogen cannot be appropriately attenuated (Baxter 
2007). 
Killed/inactivated vaccines are similar to the toxoid vaccine, however, they stimulate an 
antibody response against a range of antigens (Baxter 2007). In the name, 'killed' refers to a 
bacterial vaccine and 'inactivated' refers to a viral vaccine. Killed or inactivated vaccines are 
produced by using chemicals, heat, or radiation to kill the microbes causing the disease (Types 
of.. ;2017). The response generated takes about two weeks to occur but a follow-up encounter 
would activate the memory B cells and induce a much quicker response that would take about 
one or two days (Baxter 2007). Because the microbes cannot replicate in the host, multiple doses 
are typically needed along with an adjuvant in the vaccine in order to generate a strong response 
(Baxter 2007). An example of a killed/inactivated vaccine is the vaccine for hepatitis A. 
How does a vaccine work? 
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What has been described thus far are the basic components of the immune system. This 
knowledge can be used to understand how a vaccine works. There are two types of immunity, 
active and passive which were described previously, and therefore two types of vaccines. An 
active vaccine works to induce the primary immune response. This stimulates B cell 
proliferation, T cell sensitization, and an antibody response (Bartlett et al 2009). Some of the B 
cells can then remain as memory B cells. When the memory B cells then later come into contact 
with an antigen it recognizes from the given vaccine they begin to divide and differentiate 
quickly (Bartlett et al 2009). They differentiate into plasma cells that secrete antibodies that work 
to stop or limit an initial infection and work to kill infected cells (Bartlett et al 2009). Antibodies 
do this by many methods. They can neutralize pathogens by preventing them from attaching, 
cause pathogens to aggregate, or paralyze pathogens (Forthal2014). This is what an active 
vaccine aims to do, introduce an antigen so that the primary response is made. This allows the 
formation of memory cells that are now present if the pathogen is encountered and a faster 
secondary response can be mounted. This secondary response ensures protection for the 
individual against whatever disease for which the vaccine was given. Most vaccinations induce 
this type of immunity (Bartlett et al 2009). A passive vaccine uses a globulin product and the 
direct delivery of an antibody to protect against a specific antigen. This kind of vaccine only 
provides short-lived immunity (Bartlett et al 2009). 
Smallpox: the first vaccine 
Smallpox is a disease that is caused by the virus variola and is a highly contagious 
disease. It is spread by droplets, in aerosol form, or by contact with infected sores or clothing 
(Baltimore R and McMillian J 2002). The virus incubates for a short period of one to two weeks 
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and then a rash develops on the face and limbs, along with spots on mucus membranes 
(Baltimore Rand McMillian J 2002). The rash and sores are the distinct characteristics of 
smallpox. There are four different types of smallpox: the standard type, hemorrhagic (variola 
major), malignant (variola major), and variola minor. Smallpox had a death rate of 30% or 
greater during epidemics (Baltimore Rand McMillian J 2002). This varied however depending 
on which type of smallpox a person had or how severe the case. However, there has not been a 
case of smallpox in the world since 1977. This is because of the creation of the smallpox 
vaccine, the first vaccine to be created. 
The smallpox vaccine was initiated by Edward Jenner, an English physician. Before the 
creation of the smallpox vaccine, there were other methods in place to reduce the spread of 
smallpox. This method was called variolation or inoculation. Inoculation was conducted by 
taking "matter" from the sore of someone with smallpox and injecting it subcutaneously into an 
un-inoculated person (Riedel 2005). This method did not work perfectly though, as people still 
could spread the disease, and other diseases were contracted via the transmission process. But 
once a person had smallpox they were immune to it and would not contract it a second time. As a 
teen, Edward Jenner heard that those who had cowpox were then immune from smallpox. Many 
years later, after studying many subjects such as biology and medicine, among others, Jenner had 
the idea of transferring cowpox to be used in protection against smallpox (Riedel2005). He then 
tested his theory on an 8 year old boy whom he inoculated with cowpox and later inoculated with 
smallpox. The boy did not develop cowpox or smallpox. Edward Jenner began to tell his friends 
and colleagues about his discovery. This was in 1796 but the use of the vaccination did not start 
spreading in Europe until 1800 (Riedel 2005). It then made its way over to the United States. 
Edward Jenner named the process vaccination because the Latin word for cow is vacca and 
cowpox is vaccinia (Riedel 2005). 
Other vaccines 
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Since the creation of the first vaccine for smallpox, many other vaccines have been 
produced for a variety of diseases. Most of the vaccines are for diseases that are common in the 
world and easily prevented. These vaccines have certain rules that go with them that dictate 
when they should be administered and when they should not be administered. Some information 
about the diseases and the vaccines that go with them will be provided here but more information 
can be found on www.cdc.gov/vaccines and www.vaccines.gov. The vaccines covered here are: 
chickenpox, measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, pneumococcal, and 
influenza. 
Chickenpox 
Chickenpox is also known as varicella and is a disease that most people are familiar with 
as it is a common disease in children. Before the creation ofthe vaccine there were about 11 ,000 
people hospitalized each year in the United States for the disease and about 1 00 people died from 
it each year (Vaccines by ... 2016). A chickenpox infection can cause itchiness, rashes, fever, and 
fatigue. It is usually a mild disease but can become serious and cause other problems such as 
pneumonia, brain damage, or even death (Vaccines by . . . 2016). This vaccine works to prevent 
chickenpox but someone who received the vaccine may still get the dis~ase . However, it will not 
be a severe case and will most likely be mild. Typically children are the ones who receive the 
chickenpox vaccine but it can be given to adults. The standard is for children ages 12-15 months 
to get their first dose followed by a second dose at ages 4-6 years (Vaccines by . . . 20 16). Anyone 
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over 13 years old can get the doses 28 days apart. Adults who have not proven they are immune 
should receive the standard two doses ofthe single antigen varicella vaccine (Adults Schedule 
2017). To prove they are immune a laboratory test can be done in order to determine immunity. 
The test is a titer which determines how many antibodies are present in a person' s blood. If the 
titer shows an adult is immune then they would not need the vaccine (What is a titer? ... 2015). 
MMR 
Some vaccines are combined together in one dose so that only one shot needs to be given. 
One example of this is the MMR vaccine which includes the measles, mumps, and rubella 
vaccines. This vaccine can also include the chickenpox vaccine and it is then called MMRV 
where the V stands for varicella. Children should receive two doses of the MMR vaccine. The 
first dose should be given between 12 and 15 months of age. The second dose should be given 
between the ages of 4 and 6 (Diseases and .. . 2017). Adults can also receive the vaccine if they 
did not get it as a child. 
Measles 
The measles disease is caused by a virus and is very contagious. The disease is spread by 
coughing or sneezing. The symptoms of measles include fever, cough, runny nose, sore throat, 
and a rash covering the body (Diseases and ... 2017). It can also cause an ear infection, diarrhea, 
pneumonia, damage to the brain, or even death (Diseases and ... 2017). The vaccination of 
measles began in 1963, but before it began about 3 to 4 million people would get measles every 
year in the United States. There were about 500,000 cases reported to the CDC and of these, 
48,000 people were hospitalized, 1,000 people got encephalitis, and about 400 to 500 people died 
(Vaccines by ... 2016). The measles vaccine has caused a reduction in the spread of measles by 
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greater than 99% in the United States. But measles still occurs in other countries and people who 
are not vaccinated and travel to these countries can get the disease and bring it back to the U.S. 
(Vaccines by ... 2016). In recent years, however, there have been large outbreaks of measles. In 
2014, 667 cases of measles were reported, in 2015, 188 cases were reported, and in 2016, 70 
cases were reported (Measles Cases ... 2017). Some of these cases were thought to be caused by 
a traveler from overseas who brought it back to the United States. Other cases were determined 
to be caused by unvaccinated communities (Measles Cases ... 2017). 
Mumps 
Mumps is a disease that is also caused by a virus. Its symptoms include the swelling of 
salivary glands, puffy cheeks, swollen jaw, fever, headache, loss of appetite, fatigue, and aching 
muscles (Diseases and ... 2017). The mumps vaccine is about 88% effective if two doses are 
received. The vaccination for mumps began in 1967 and since then the cases of mumps has been 
reduced by 99% in the United States (Vaccines by ... 20 16). Mumps still does occur, although it 
is typically in school settings such as high school or college. 
Rubella 
Rubella is a disease that is also caused by virus and its symptoms include mild fever and 
rash over the entire body in children. But it can also cause birth defects or miscarriage if a 
pregnant women gets infected (Vaccines by ... 2016). One dose of the rubella vaccine is about 
97% effective. The last epidemic of rubella occurred in 1964-65 and about 12.5 million cases 
were reported. However, as of 2004, rubella has been eliminated from the United States 
(Vaccines by ... 20 16). Rubella still does occur in other countries however and people who are 
not vaccinated and travel to these countries can get the disease and bring it back to the U.S 
(Vaccines by ... 2016). 
DTap, DT, Td, Tdap 
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Another example of a combined vaccine is the vaccine that combines the diphtheria, 
tetanus, and pertussis vaccines. There are four of these vaccines available: DTaP, DT, Td, and 
Tdap. DTaP and DT are given to younger children who are under 7 years old. Td and Tdap are 
given to older children and adults (Diseases and ... 2017). DTaP stands for diphtheria and 
tetanus toxoids and acellular pertussis. Children should get five doses of the DTaP or DT vaccine 
and these doses should occur at ages 2 months, 4 months, 6 months, 15-18 months, and 4-6 years 
(Diseases and ... 2017). The DT vaccine does not contain the pertussis vaccine. Anyone over 6 
years old cannot get the DTaP vaccine and can instead get the Td or Tdap vaccine. The Td 
vaccine is used as a booster vaccine that is given every 1 0 years or if someone is exposed to 
tetanus (Diseases and ... 2017). One dose ofTdap is given to anyone 11-18 years old and 19 
years or older. Pregnant women should also get the Tdap vaccine between 27 and 36 weeks of 
the pregnancy (Diseases and ... 20 17). 
Diphtheria 
Diphtheria is a respiratory disease that is caused by the bacteria Corynebacterium 
diphtheria. The symptoms of diphtheria are sore throat, weakness, fever, and swollen glands. 
The Corynebacterium diphtheria bacteria attaches to the respiratory system and releases a poison 
that kills the tissue and causes the formation of a thick coating that builds up on the nose or 
throat. This build up can make it difficult for a person to breathe or swallow (Vaccines by ... 
20 16). The route of transmission of diphtheria is via droplets from coughing or sneezing. In 
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1921,206,000 cases of diphtheria were reported and of those there were 15,520 deaths (Vaccines 
by ... 20 16). But in the past 10 years there have been fewer than five cases reported in the United 
States (Vaccines by . . . 20 16). However, it is still a problem around the world. 
Tetanus 
Tetanus is an infection that is also known by the name lockjaw and is caused by the 
bacteria Clostridium tetani. This bacteria releases a toxin into the body and causes contractions 
in the muscles (Diseases and ... 2017). This symptom of muscle contraction is why Tetanus is 
called lockjaw because the muscles in the jaw contract and ' lock up' . This makes it difficult for a 
person to breathe or swallow (Diseases and ... 20 17). Other symptoms include seizures, muscle 
spasms, and paralysis (Diseases and ... 2017). Tetanus is not an infectious disease that can be 
spread to other people. The Clostridium tetani bacteria can infiltrate the body through a cut on 
the skin and can be found in soil, dust, or manure (Diseases and ... 2017). Tetanus is included in 
the DTaP vaccine that is given to younger children but the immunity to it decreases as time 
passes. This means that a booster shot is needed for older children and adults which is given with 
the Tdap vaccine. The Tdap vaccine contains a full dose of the tetanus vaccine but lower doses 
of the diphtheria and pertussis vaccines (Diseases and ... 2017). It is recommended that a booster 
is given every 1 0 years. 
Pertussis 
Pertussis is a bacterial disease that is also known by the name whooping cough. It is 
caused by the bacteria Bordetella pertussis and is a highly contagious disease (Diseases and ... 
20 17). It is spread by sneezing or coughing near someone who then can breathe the bacteria into 
their body. The symptoms of pertussis include severe coughing, vomiting, and trouble sleeping. 
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This symptoms can then lead to other complications such as weight loss, incontinence, fractured 
ribs, or passing out caused from excessive coughing (Diseases and . .. 20 17). These symptoms 
will typically appear between 7 and 1 0 days but could show up as late as 6 weeks (Diseases 
and ... 20 17). Pertussis is usually more severe for babies who have not gotten the first vaccine 
yet. Many babies are hospitalized with pertussis and of those 1 in 4 will get pneumonia, about 1 
or 2 in 1 00 will undergo convulsions, and 1 or 2 in 1 00 will die from the disease (Diseases and ... 
2017). 
Polio 
Polio or poliomyelitis is an infectious disease that is cause by a virus. The virus resides in 
the throat or in the tract of the intestines and affects the nervous system (Diseases and ... 2017). 
Polio can be spread by contact with secretions from the mouth or nose of an infected person or 
by coming into contact with the feces of someone who is infected (Diseases and .. . 20 17). As 
many as 95% of people with polio experience no symptoms but others can have flu-like 
symptoms, stiff neck or back, or painful limbs. Less than 1% of those with polio with experience 
permanent paralysis of their limbs and other muscles which can lead to disability or even death 
(Diseases and .. . 2017). The polio vaccine consists of two different kinds, one is the inactivated 
polio vaccine and the other is the oral polio vaccine. The inactivated polio vaccine has been in 
use in the United States since 2000 (Diseases and . . . 2017). The vaccine is typically given to 
children and consists of four doses given at 2 months of age, 4 months, 6 to 18 months, and 4 to 
6 years old (Diseases and .. . 2017). Adults should be given three doses of the vaccine if they did 
not receive it as a child or if they are traveling to somewhere that has a high risk for polio 
(Diseases and ... 2017). The polio vaccine was first put into use in 1955 when polio was common 
in the United States. In fact, polio harmed over 35 ,000 people in the U.S every year (Diseases 
and ... 20 17). Since 1979 the United States has been free from polio, although it still occurs in 
other places in the world (Diseases and . .. 2017). 
Pneumococcal Disease 
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Pneumococcal disease is a bacterial disease caused by the Streptococcus pneumonia 
bacteria (Diseases and ... 2017). Pneumococcal disease is manifested in different ways, such as 
pneumonia, bacteremia (blood infection), meningitis (infection of the brain and spinal cord), and 
otitis media (ear infections) (Diseases and .. . 2017). The symptoms vary depending on the 
manifestation of the disease and it is spread by contact with secretions from coughing or 
sneezing (Diseases and .. . 2017). The pneumococcal vaccine consists of two kinds, the 
pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine 
(PPSV23). The numbers in the vaccine indicate how many types of the 90+ types of 
pneumococcal bacteria the vaccines protects against (Diseases and ... 2017). PPSV23 does not 
include protection against pneumonia while PCV13 does provide protection against it. PCV13 is 
given as four doses to children at ages 2 months, 4 months, 6 months, and 12 to 15 months 
(Diseases and . .. 2017). It is given as one dose to adults who are over 65 years old and who have 
not received the vaccine. This dose should be followed up by a dose of the PPSV23 one year 
after (Diseases and .. . 20 17). Some children or adults between 6 and 64 years old who are at an 
increased risk for a pneumococcal disease should receive one dose ofPCV13. One dose of 
PPSV23 is also recommended for adults who are over 65 years old and any person with a long 
term health issue (Diseases and ... 2017). 88% of pneumococcal disease in children has fallen 
since the creation of this vaccine (Vaccines by ... 2016). 
Influenza 
One of the most common vaccines known is the influenza or flu vaccine. The flu is 
caused by the influenza virus and it is spread by close contact to an infected person or by 
coughing or sneezing (Vaccines by ... 2016). The flu usually is prominent in the United States 
during the months of October to May. Anyone is susceptible to flu, but infants, elderly people, 
pregnant women, or anyone with a weak immune system are more susceptible. The symptoms 
include fever, aching muscles, fatigue, cough, headache, and a stuffy or runny nose (Vaccines 
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by ... 2016). The flu vaccine can do many things including preventing the flu, preventing the 
spread ofthe flu, and weaken the severity of the flu if a person were to still get it. It is 
recommended that every person get one dose of the vaccine each year during flu season 
(Vaccines by ... 20 16). The reason the vaccine is needed every year is because there are a lot of 
flu viruses and the ones causing the flu each year can change. The vaccines are made so that they 
protect against three or four of the flu viruses that are thought to cause the flu that year (Vaccines 
by ... 2016). There are two different kinds of the flu vaccine called trivalent and quadrivalent. 
The trivalent vaccine provides protection against two influenza A viruses and one influenza B 
virus. This vaccine can be given in different ways, such as the standard dose for those older than 
6 months, the high dose for those older than 65 years, the recombinant shot that is free of eggs 
for those older than 18, and a shot made with adjuvant for those older than 65 (Diseases and ... 
20 17). The quadrivalent vaccine provides protection against two influenza A viruses and two 
influenza B viruses. This vaccine has two types, the intradermal quadrivalent shot for those 
between 18 and 64 years old, and the quadrivalent shot for those older than 4 years (Diseases 
and ... 2017). Many people believe they can get the flu from the flu vaccine but this is not true. 
The vaccines do not contain the flu virus, instead they contain the killed virus or do not contain 
the virus (Diseases and . . . 2017). 
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Vaccine Safety and Autism 
Concerns over-vaccines are legitimate as it is a parent's responsibility to ensure that their 
children are and remain healthy. This has led to parents voicing their concerns and potentially 
not vaccinating their children. While these worries are valid, it is important for parents to educate 
themselves as much as possible to make a fully informed decision. The concerns exist for a 
variety of reasons. As reported by the American Academy of pediatrics, 
" ... 44% of parents reported concern over pain associated with receiving multiple 
injections during a single visit, 34% expressed unease about receiving too many vaccines at a 
single visit, 26% worried about the development of autism or other potential learning difficulties 
after receiving vaccines, 13.5% expressed concern that vaccines could lead to chronic illnesses, 
and 13.2% stated that vaccines were not tested enough for safety before their use" (Edwards K 
and Hackell J 2016). 
But vaccines are made for a specific reason, to provide protection to children and others 
and prevent harmful diseases from becoming prevalent. Since vaccines are a source of protection 
and prevention against illness it would not make since for them to cause more or other harmful 
side effects. This is a serious business and the safety of vaccines are taken seriously as well. 
According to a clinical report from the American Academy of Pediatrics, 
"The current system for developing, testing, and regulating vaccines requires that the 
vaccines demonstrate both safety and efficacy before licensure and that long-term safety is 
monitored" (Edwards K and Hackell J 2016). 
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There are many safety measures in place for vaccines from when they are being produced 
to even after they are on the market. Ingredients in vaccines are tested for many qualities such as 
. 
purity, potency, sterility, consistency, activity, and stability (DiPasquale et al2016). The 
ingredients have to be the highest purity and their origins must be able to be traced (Di Pasquale 
et al2016). Once a license is gained for a vaccine, it must still undergo quality control tests, non-
clinical tests, toxicity tests, and safety tests (DiPasquale et al2016). The sites where the 
vaccines are produced are also inspected and approved before production begins, along with 
inspections happening regularly after production begins (Di Pasquale et al 20 16). When applying 
for a license, a Risk Management Plan is produced. In this plan risks are named and plans on 
how to deal with these risks are given (Di Pasquale et al 20 16). After a license is gained one 
method of safety still in place is passive surveillance in which the public or healthcare providers 
report any adverse effects following immunization (AEFis) (DiPasquale et al2016). 
Despite all that goes into making vaccines safe, there are many myths and controversies 
surrounding vaccines that keep parents from having their children vaccinated. Some simply 
believe that vaccines are not needed (Edwards K and Hackell J 20 16). In a survey conducted by 
the American Academy of Pediatrics in 2006 showed that 75% of pediatricians had a parent that 
refused a vaccine and in 2013 this number had increased to 87% (Edwards K and Hackell J 
2016). Between 2006 and 2013 there was also an increase in parents rejecting one or more 
vaccines with this number increasing from 9.1% to 16.7% (Edwards K and Hackell J 20 16). 
However, one ofthe biggest myths surrounding vaccinations is the idea that vaccinations can 
cause autism. 
Since the publication of an article (that has since been retracted) relating the MMR 
vaccine to intestinal disorders and autism many parents have had more concerns over vaccinating 
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their children. Many studies conducted since have shown that there is no link between the MMR 
vaccine and autism. A study published in 1999 was conducted in the United Kingdom and used 
data on children diagnosed with an autism disorder from eight North Thames health districts 
(Taylor et al 1999). It was found that the cases of autism did increase each year steadily but there 
was not a major change when the MMR vaccine was introduced (Edwards K and Hackell J 
2016). Therefore itwas concluded that there is not a causal link between the MMR vaccine and 
autism. However, the study points out how there is not much data on the occurrence of children 
with autism before and after the MMR vaccine was first in use in the United Kingdom (1988) 
(Taylor et al 1999). The study also suggested that the original reasoning for the link between 
MMR and autism is the fact that the vaccine is given around the same time that most parents 
notice symptoms of autism in their children (Taylor et al 1999). Therefore, this correlation would 
be expected but it has not been proven. 
A study conducted in Denmark to determine if there is a link between the MMR vaccine 
and autism was published in 2002. This study was a retrospective study on children born in 
Denmark from January 1991 through December 1998. They found that 82% ofthe children had 
received the MMR vaccine and of that 82% (440,655), 316 children had been diagnosed with 
autism and 422 had been diagnosed with an autism-spectrum disorder (Madsen et al2002). The 
study also commented on how MMR vaccine use appeared to occur at the same time there was 
an increase in autism diagnosis. However, they found that this was not the case in Denmark 
(Madsen et al2002). It was also found that there was a similar incidence for autism in both 
children vaccinated and unvaccinated (Madsen et al2002). The study concluded that based on 
their evidence there was no link found between the MMR vaccine and the development of 
autism. 
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Vaccines are Important 
Everyone in the world experiences an illness at some point in their lives. This could just 
be a cold or a more serious disease. Most people can easily get over a cold but it' s not as easy to 
get over a serious disease. This is where the benefits of vaccines can be seen. A vaccine works to 
prevent and protect an individual from getting a disease in the first place. Since the invention of 
the vaccine by Edward Jenner in 1796, vaccine' s benefits to society have been clear. The vaccine 
for smallpox has allowed the disease to become eradicated from the world. Other vaccines have 
led to reduced cases of many diseases that would otherwise cause much illness. Vaccines have 
been invented for many common diseases in the world, such has the flu, measles, mumps, 
rubella, and more. Having concerns about vaccines and the risks associated with them is 
understandable. But it important to be educated about them, not just about the risks but also 
about the abundant benefits. It is important that children and adults are vaccinated for the many 
diseases with a vaccine because they are not eradicated diseases. They might not be a problem 
now but if people continue to not vaccinate their children then these disease can become a huge 
problem. The article Vaccine impact: Benefits for human health said it best, 
"Once a well-known and much-feared disease appears to have disappeared, individuals, 
including healthcare professionals, no longer view ongoing prevention with the same sense of 
urgency. Reduced coverage is inevitably associated with resurgence in disease, with outbreaks 
potentially leading to significant morbidity and loss of life. Ensuring the continued success of 
immunisation programmes is the responsibility of all: individuals, healthcare professionals, 
government and industry," (Doherty et al2016). 
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